Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
Abstract Background The development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and developed ghost cell glaucoma and analyzed...
Main Authors: | Jun Xu, Meng Zhao, Ji peng Li, Ning pu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-020-01422-z |
Similar Items
-
Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01) -
Effect of intravitreal injection of Bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: Na Meng, et al.
Published: (2016-05-01) -
Effect of Ranibizumab intravitreal injection as an adjunct before vitrectomy surgery in the treatment of patients with proliferative diabetic retinopathy
by: Yang Zhang, et al.
Published: (2015-08-01) -
Bevacizumab-assisted surgery in the treatment of severe proliferative diabetic retinopathy
by: Yan Liu, et al.
Published: (2018-02-01) -
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
by: Sakamoto M, et al.
Published: (2018-11-01)